State Street Corp Novo Nordisk A S Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, State Street Corp holds 6,227,361 shares of NVO stock, worth $656 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,227,361

Previous 6,370,053 2.24%

Holding current value

$656 Million

Previous $909 Million 18.45%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $17 Million - $20.8 Million	-142,692 Reduced 2.24%	6,227,361 $741 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $25 Million - $29.9 Million	-203,637 Reduced 3.1%	6,370,053 $909 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $898,261 - $1.2 Million	8,797 Added 0.13%	6,573,690 $844 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $10.1 Million - $12.1 Million	-114,767 Reduced 1.72%	6,564,893 $679 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $299 Million - $656 Million	3,286,538 Added 96.86%	6,679,660 $607 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $7.78 Million - $8.61 Million	-49,856 Reduced 1.45%	3,393,122 $549 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $5.95 Million - $7.16 Million	-44,965 Reduced 1.29%	3,442,978 $548 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $4.19 Million - $5.53 Million	-40,872 Reduced 1.16%	3,487,943 $472 Million
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $2.58 Million - $3.16 Million	-27,044 Reduced 0.76%	3,528,815 $352 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $6.48 Million - $7.64 Million	-62,745 Reduced 1.73%	3,555,859 $396 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $9.62 Million - $11.6 Million	-103,290 Reduced 2.78%	3,618,604 $406 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $14.2 Million - $17.4 Million	-148,303 Reduced 3.83%	3,721,894 $417 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $9.63 Million - $12.2 Million	-114,109 Reduced 2.86%	3,870,197 $372 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $2.22 Million - $2.78 Million	-32,853 Reduced 0.82%	3,984,306 $334 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $10.1 Million - $11.4 Million	-149,881 Reduced 3.6%	4,017,159 $275 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $628,038 - $725,454	-9,830 Reduced 0.24%	4,167,040 $291 Million
Q3 2020 Nov 10, 2020	SELL	$63.69 - $70.22 $3.32 Million - $3.66 Million	-52,077 Reduced 1.23%	4,176,870 $290 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.45 Million - $1.68 Million	-24,746 Reduced 0.58%	4,228,947 $277 Million
Q1 2020 May 11, 2020	BUY	$49.46 - $64.78 $210 Million - $276 Million	4,253,693 New	4,253,693 $259 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Novo Nordisk A S Transaction History